-
1
Table 1_Deep learning-based survival analysis of bladder cancer patients in the Putuo District, Shanghai, China.docx
Foilsithe / Cruthaithe 2025Ábhair: -
2
Supplementary Tables from The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer
Foilsithe / Cruthaithe 2025Ábhair: -
3
Supplementary Video from The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer
Foilsithe / Cruthaithe 2025Ábhair: -
4
Supplementary Data from The m<sup>6</sup>A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I–Mediated Immune Response
Foilsithe / Cruthaithe 2025Ábhair: -
5
Data Sheet 1_Characterization of Ty21a immunostimulatory effects in the mouse bladder.pdf
Foilsithe / Cruthaithe 2025Ábhair: -
6
-
7
Figure S1 from A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma <i>In Situ</i> of the Bladder
Foilsithe / Cruthaithe 2025Ábhair: -
8
-
9
-
10
Table S5 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
Foilsithe / Cruthaithe 2025Ábhair: -
11
Table S4 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
Foilsithe / Cruthaithe 2025Ábhair: -
12
Table S2 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
Foilsithe / Cruthaithe 2025Ábhair: -
13
Table S7 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
Foilsithe / Cruthaithe 2025Ábhair: -
14
Table S3 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
Foilsithe / Cruthaithe 2025Ábhair: -
15
Table S1 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
Foilsithe / Cruthaithe 2025Ábhair: -
16
Table S6 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
Foilsithe / Cruthaithe 2025Ábhair: -
17
-
18
-
19
-
20